Jun 1, 2016

Dr. Albert Gough receives joint SBIR funding to develop a hepatotoxicity platform


Dr. Albert Gough has received funding under an SBIR entitled "Development and Evaluation of a high through IPS Hepatotoxicity Screening Platform"